SERES THERAPEUTICS INC's ticker is MCRB and the CUSIP is 81750R102. A total of 125 filers reported holding SERES THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.98 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $852 | -44.7% | 1,100,000 | 0.0% | 0.00% | -42.9% |
| Q4 2023 | $1,540 | -35.3% | 1,100,000 | +10.0% | 0.01% | -46.2% |
| Q3 2023 | $2,380 | -50.3% | 1,000,000 | 0.0% | 0.01% | -50.0% |
| Q2 2023 | $4,790 | +5.6% | 1,000,000 | +25.0% | 0.03% | 0.0% |
| Q1 2023 | $4,536 | -98.2% | 800,000 | +2091.8% | 0.03% | +2500.0% |
| Q3 2021 | $254,000 | -33.5% | 36,500 | +128.1% | 0.00% | -50.0% |
| Q2 2021 | $382,000 | +32.6% | 16,000 | +14.3% | 0.00% | 0.0% |
| Q1 2021 | $288,000 | – | 14,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 23,117,045 | $148,411,000 | 6.25% |
| Eversept Partners, LP | 1,935,825 | $12,427,997 | 1.08% |
| Kynam Capital Management, LP | 772,820 | $4,962,000 | 1.05% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 366,493 | $2,353,000 | 0.80% |
| Lion Point Capital, LP | 626,803 | $3,228,000 | 0.71% |
| FEDERATED HERMES, INC. | 18,499,136 | $118,765,000 | 0.35% |
| Knott David M Jr | 110,000 | $706,000 | 0.30% |
| Atom Investors LP | 108,820 | $699,000 | 0.25% |
| Ikarian Capital, LLC | 131,310 | $843,000 | 0.17% |
| HARVARD MANAGEMENT CO INC | 131,847 | $846,000 | 0.10% |